Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Short-term Investments (2024 - 2025)

Zenas BioPharma (ZBIO) has 2 years of Short-term Investments data on record, last reported at $175.3 million in Q3 2025.

  • For Q3 2025, Short-term Investments rose 196887.64% year-over-year to $175.3 million; the TTM value through Sep 2025 reached $175.3 million, up 196887.64%, while the annual FY2024 figure was $31.0 million, N/A changed from the prior year.
  • Short-term Investments reached $175.3 million in Q3 2025 per ZBIO's latest filing, down from $229.3 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $229.3 million in Q2 2025 and bottomed at $86000.0 in Q1 2024.